Member Info for Gareth3672

Difference between buys and sells is roughly 50K and the MMs drop the share price by 12%.
Thats a market valuation of 450k instead of the actual 250million market cap.
What a joke

Can’t see anyone shorting IMM but you never know. Good to see you Eve. We appear to have a few trolls in here.

FDA website clearly shows that drugs to treat cancer muscular dystrophy and even acne are still being approved in August and even more recently in September, please don’t tell me that other drugs are not being looked at, It’s in black-and-white here, others should be careful when reading messages that say end of Q1 21 it’s in black-and-white here, others should be careful when reading messages that say end of Q1 21. https://www.fda.gov/drugs/new-drugs-fda-cders-new-molecular-entities-and-new-therapeutic-biological-products/novel-drug-approvals-2020

Rebarm not sure I quite agree with you there, whilst I agree Covid will take precedence it is ridiculous to think that other diseases are not being looked at for vaccines or testing, hospitals are not full of Covid patients in the UK but they are still full of patients with other diseases, life still goes on.

Around the 13 to 17p mark until we get news, some might say a trading opportunity, but so close to the FDA approval? Balls of steel would be required to sell.

If news is due out by the 7th of September, that means you only have this week to invest. Monday could be a very busy day.

If shares are due to start trading on the 7th of September, might one be correct in thinking that news could be forthcoming prior to the 7th of September?

Nolupus is likely sat on a table opposite me tucking into a nice English Fried breakfast reading all the messages on here I’m thinking yes were 20% down today but with a buying opportunity I think will be on the up tomorrow.

It was a surprise and such good news is due over the next coming days

Score you have to admit that IMM are in a far better position now having done the phase 3 trial and allowed Avon to do due diligence on the results, Avion would not be ploughing money into this if they thought it would not meet the end target with a high degree of certainty.

Eve, when someone who holds such a large amount as you writes a message below that says “let it crash and let it crash hard” I know that they’re going to write another message later on saying “I bought in some more today” :)

Pangolin, of course 14p is not 14p now, but likewise the cash flow today is not like it was yesterday, I’m not going to do a calculation to work out the exact difference between shares that were 17p yesterday and shares that were bought today at 11 as I feel that will be wasting my time, especially when the share price will rise on the next AarPangolin, of course 14p is not 14p now, but likewise the cash flow today it’s not like it was yesterday, I’m not going to do a calculation to work out the exact difference between shares that were 17p yesterday and shares that would bought today at 11 as I feel that will be wasting my time colour especially when the share price will rise on the next RNS. What is more concerning for me is should I go for the option of the fried breakfast or just stick with the fruit salad bowl that I’m currently tucking into.

Right, I see a 15 to 20% discount allowing others to buy in around 13.5p which is what I bought in at, am I moaning, nope, as it will change nothing, the big boys were just given another chance to get in, go with the flow swim with the tide.
I am however going to have a lovely breakfast with a nice cup of coffee in the knowledge that the next couple of RNS will lift the share price.

What a buying opportunity, I mean really, I never thought you’d be able to get back in again at 13p prior to an RNS from the FDA approving Lupuzor for an SPA.
Share price will recover today at some point if not this week, as I said earlier calm down....

Eve all valid questions which I think you should send to Tim McCartney, perhaps do it on Twitter at ImmuPharma.

I would however also suggest that you do not sell if this does reach the 11p placing price because undoubtedly it’s only a chunk report at that price, the rest yesterday at 17p we might find a level playing field around about 13p /14p today and from then on build back up again on positive news.

I mean seriously is this the first time you have seen a placing? Have they cancelled the RNS from the FDA for the SPA? Was the placing oversubscribed? Some posters on here need to calm down it will rise again even if it does drop today, many will use this as an opportunity to buy back in

So which RNS do we think is coming first? Ureka or Lupuzor?

Doing a bit of research on Immupharma I read the previous phase three trial only took 24 weeks once patients had been allocated, I’m pretty sure that patients will have already been sourced via Avion from the previous phase three trial and these patients will be notified as soon as the FDA approve the SPA.

For those thinking the share price has now peaked and will drop back, I personally think your wrong, the same message was said on here at 13, then 14, then 15... we have to much in the pipeline to see this drop now. 30p still a target IMO.

Spwcapital... good write up below.

Of course if we get other news of Ureka I’m also happy to keep holding here, gotta play this one by ear. Will have to jump back in as we get close to finding out results of new phase 3. How long did IMM take to start and complete from first initial patient taking Lupuzor? Anyone know?

Each to their own selling and I am sure those that sold out hoping for this to drop to 13p again are kicking themselves now. I’ll be happy just to wait for 30p or anywhere in that range post FDA SPA.